Designing and implementing methodologically rigorous pharmacoepidemiology studies satisfying post-marketing regulatory commitments or generating needed real-world evidence (RWE) in numerous therapeutic areas and in a variety of diverse health settings. Experiences include: designing post-authorization safety studies (PASS) and real-world evidence (RWE) studies; producing protocols, statistical analysis plans, and reports for submission to regulatory agencies; support of large, multidisciplinary teams in implementing multi-national and multi-database studies; interpreting and synthesizing evidence from multiple sources; methodological consulting for numerous practice areas.

Adjunct assistant professor in the Department of Epidemiology, Gillings School of Global Public Health at UNC Chapel Hill. I provide guest lectures about various methodological and substantive topics, serve on student dissertation/thesis committees, and serve as a point of contact for students contemplating careers in consulting fields.

Research Assistant Professor in the Department of Epidemiology, Gillings School of Global Public Health specializing in pharmacoepidemiology, comparative effectiveness research, and clinical epidemiology.

Researcher in the Pharmacoepidemiology Program of the Department of Epidemiology. I conduct database studies of medication comparative safety and effectiveness. I also investigate methods in study design and analysis in observational drug research.

PhD candidate in pharmacoepidemiology.Doctoral advisor: M. Alan Brookhart.Dissertation title: Acute kidney injury in statin initiators: patterns of initiation and applications in observational drug safety research.

1. Basic SAS programming for first-year epidemiology graduate students2. Introductory epidemiology for non-epidemiology public health graduate students

Literature searches and reviews.Patient database management.Statistical analysis.Manuscript preparation.